CSL Ltd (CSLLY)

110.81
-3.19(-2.80%)
  • Volume:
    30,816
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    110.13 - 114.85

CSLLY Overview

Prev. Close
114
Day's Range
110.13-114.85
Revenue
-
Open
114.85
52 wk Range
94.05-117.49
EPS
-
Volume
30,816
Market Cap
101.3B
Dividend (Yield)
1.11
(0.99%)
Average Vol. (3m)
32,619
P/E Ratio
-
Beta
-
1-Year Change
-3.53%
Shares Outstanding
455,672,800
Next Earnings Date
-
What is your sentiment on CSL Ltd?
or
Market is currently closed. Voting is open during market hours.

CSL Ltd Company Profile

Employees
25000

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellSellStrong Buy
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Buy
SummaryNeutralStrong SellStrong SellStrong SellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.